Page last updated: 2024-08-22

platinum and Vaccinia

platinum has been researched along with Vaccinia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abaid, LN; Ahmad, S; Brown, JV; Holloway, RW; Kendrick, JE; LeBlanc, J; McKenzie, ND; Mendivil, AA; Mori, KM	1

Other Studies

1 other study(ies) available for platinum and Vaccinia

Article	Year
Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial. JAMA oncology, 2023, 07-01, Volume: 9, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Smallpox; Vaccinia	2023

Article

Year

Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial.

JAMA oncology, 2023, 07-01, Volume: 9, Issue:7

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Smallpox; Vaccinia

2023